Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Efficacy and safety of weekly vitamin D in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial.

< BACK TO ARCHIVE


Papers: 6 Feb 2021 - 12 Feb 2021


Human Studies


2021 Feb 10


Clin Rheumatol


http://www.ncbi.nlm.nih.gov/pubmed/33570701?dopt=Abstract

Efficacy and safety of weekly vitamin D in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial.

Authors

Efficacy and safety of weekly vitamin D in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial.
Lozano-Plata L I, Vega-Morales D, Esquivel-Valerio J A, Garza-Elizondo M A, Galarza-Delgado DA, Silva-Luna K, Serna-Peña G, Sifuentes-Ramírez J, de Garza-Guerra A J, Díaz-Niño de Rivera R
Clin Rheumatol. 2021 Feb 10.
PMID: 33570701.

Abstract

FM is a chronic musculoskeletal disorder characterized by the presence of generalized pain. There are contradictory results regarding the prevalence and supplementation effect of vitamin D deficiency on FM patients. We aim to determine the safety and efficacy of a 12-week vitamin D supplementation on FM patients.
Read This Paper